US Stock MarketDetailed Quotes

TTOO T2 Biosystems

Watchlist
  • 0.8000
  • -0.0509-5.98%
Close Nov 4 16:00 ET
  • 0.8198
  • +0.0198+2.48%
Post 20:01 ET
13.98MMarket Cap0.03P/E (TTM)

T2 Biosystems Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
-0.61%1.95M
-0.82%2.06M
-67.75%7.19M
-69.38%1.68M
-59.97%1.47M
-66.77%1.96M
-71.27%2.08M
-20.50%22.31M
-21.45%5.48M
-50.50%3.68M
Operating revenue
-0.61%1.95M
-0.82%2.06M
-67.75%7.19M
-69.38%1.68M
-59.97%1.47M
-66.77%1.96M
-71.27%2.08M
-20.50%22.31M
-21.45%5.48M
-50.50%3.68M
Cost of revenue
-44.69%2.69M
5.18%4.2M
-26.88%15.36M
-29.27%2.57M
-35.50%3.93M
-4.17%4.87M
-35.62%4M
1.48%21.01M
-32.13%3.64M
28.92%6.09M
Gross profit
74.49%-741K
-11.68%-2.14M
-730.89%-8.17M
-148.54%-895K
-1.87%-2.45M
-450.00%-2.91M
-286.30%-1.92M
-82.39%1.3M
13.97%1.84M
-188.92%-2.41M
Operating expense
-12.93%8.83M
-11.14%10.46M
-30.81%38.98M
-24.87%8.42M
-35.46%8.64M
-35.98%10.15M
-25.91%11.77M
11.95%56.34M
-5.75%11.21M
-10.24%13.39M
Selling and administrative expenses
-13.07%5.47M
-7.69%6.74M
-18.92%24.83M
-19.82%5.26M
-14.78%5.98M
-19.53%6.3M
-20.92%7.3M
7.35%30.63M
0.15%6.55M
-17.80%7.02M
Research and development costs
-12.70%3.36M
-16.77%3.72M
-44.96%14.15M
-31.98%3.17M
-58.23%2.66M
-52.02%3.85M
-32.83%4.47M
17.95%25.72M
-12.96%4.66M
-0.14%6.38M
Operating profit
26.63%-9.58M
7.94%-12.6M
14.34%-47.15M
0.53%-9.32M
29.77%-11.1M
13.10%-13.05M
7.88%-13.69M
-28.09%-55.05M
8.85%-9.37M
-29.38%-15.8M
Net non-operating interest income expense
68.98%-478K
22.54%-1.18M
12.18%-5.34M
24.02%-1.16M
28.27%-1.12M
-14.66%-1.54M
7.59%-1.52M
18.71%-6.08M
17.85%-1.53M
18.45%-1.56M
Non-operating interest expense
-68.98%478K
-22.54%1.18M
-12.18%5.34M
-24.02%1.16M
-28.27%1.12M
14.49%1.54M
-7.76%1.52M
-19.91%6.08M
-21.80%1.53M
-18.71%1.56M
Other net income (expense)
-86.78%1.09M
108.89%245K
376.77%2.42M
-82.46%140K
-21,300.00%-3.21M
593.42%8.25M
-30,722.22%-2.76M
-171.88%-874K
16,060.00%798K
-109.20%-15K
Gain on sale of security
-87.12%1.06M
96.14%-80K
811.94%5.43M
-96.36%31K
-1,303.23%-746K
590.39%8.21M
-18,954.55%-2.07M
-175.45%-762K
503.32%851K
-61.96%62K
Special income (charges)
----
----
-1,562.91%-2.51M
--0
---2.51M
----
----
---151K
---151K
--0
-Less:Impairment of capital assets
----
----
1,562.91%2.51M
--0
--2.51M
----
----
--151K
--151K
--0
Other non- operating income (expenses)
3.23%32K
147.65%325K
-1,369.23%-495K
11.22%109K
161.04%47K
675.00%31K
-34,000.00%-682K
-81.07%39K
--98K
---77K
Income before tax
-41.22%-8.96M
24.66%-13.53M
19.23%-50.08M
-2.39%-10.34M
11.22%-15.43M
64.81%-6.35M
-8.91%-17.97M
-25.92%-62M
16.84%-10.1M
-24.44%-17.38M
Income tax
Net income
-41.22%-8.96M
24.66%-13.53M
19.23%-50.08M
-2.39%-10.34M
11.22%-15.43M
64.81%-6.35M
-8.91%-17.97M
-25.92%-62M
16.84%-10.1M
-24.44%-17.38M
Net income continuous Operations
-41.22%-8.96M
24.66%-13.53M
19.23%-50.08M
-2.39%-10.34M
11.22%-15.43M
64.81%-6.35M
-8.91%-17.97M
-25.92%-62M
16.84%-10.1M
-24.44%-17.38M
Minority interest income
Net income attributable to the parent company
-41.22%-8.96M
24.66%-13.53M
19.23%-50.08M
-2.39%-10.34M
11.22%-15.43M
64.81%-6.35M
-8.91%-17.97M
-25.92%-62M
16.84%-10.1M
-24.44%-17.38M
Preferred stock dividends
330K
0
330K
Other preferred stock dividends
Net income attributable to common stockholders
-41.22%-8.96M
24.66%-13.53M
19.66%-50.08M
-2.39%-10.34M
12.88%-15.43M
64.81%-6.35M
-8.91%-17.97M
-26.59%-62.33M
16.84%-10.1M
-26.81%-17.71M
Basic earnings per share
91.84%-0.64
97.98%-2.66
98.43%-19.19
98.19%-2.5478
98.83%-3.45
98.46%-7.84
72.89%-131.77
21.15%-1.22K
-1,914.29%-141
-3,399.41%-294.65
Diluted earnings per share
91.84%-0.64
97.98%-2.66
98.43%-19.19
98.19%-2.5478
98.83%-3.45
98.46%-7.84
72.89%-131.77
21.15%-1.22K
-1,914.29%-141
-3,399.41%-294.65
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue -0.61%1.95M-0.82%2.06M-67.75%7.19M-69.38%1.68M-59.97%1.47M-66.77%1.96M-71.27%2.08M-20.50%22.31M-21.45%5.48M-50.50%3.68M
Operating revenue -0.61%1.95M-0.82%2.06M-67.75%7.19M-69.38%1.68M-59.97%1.47M-66.77%1.96M-71.27%2.08M-20.50%22.31M-21.45%5.48M-50.50%3.68M
Cost of revenue -44.69%2.69M5.18%4.2M-26.88%15.36M-29.27%2.57M-35.50%3.93M-4.17%4.87M-35.62%4M1.48%21.01M-32.13%3.64M28.92%6.09M
Gross profit 74.49%-741K-11.68%-2.14M-730.89%-8.17M-148.54%-895K-1.87%-2.45M-450.00%-2.91M-286.30%-1.92M-82.39%1.3M13.97%1.84M-188.92%-2.41M
Operating expense -12.93%8.83M-11.14%10.46M-30.81%38.98M-24.87%8.42M-35.46%8.64M-35.98%10.15M-25.91%11.77M11.95%56.34M-5.75%11.21M-10.24%13.39M
Selling and administrative expenses -13.07%5.47M-7.69%6.74M-18.92%24.83M-19.82%5.26M-14.78%5.98M-19.53%6.3M-20.92%7.3M7.35%30.63M0.15%6.55M-17.80%7.02M
Research and development costs -12.70%3.36M-16.77%3.72M-44.96%14.15M-31.98%3.17M-58.23%2.66M-52.02%3.85M-32.83%4.47M17.95%25.72M-12.96%4.66M-0.14%6.38M
Operating profit 26.63%-9.58M7.94%-12.6M14.34%-47.15M0.53%-9.32M29.77%-11.1M13.10%-13.05M7.88%-13.69M-28.09%-55.05M8.85%-9.37M-29.38%-15.8M
Net non-operating interest income expense 68.98%-478K22.54%-1.18M12.18%-5.34M24.02%-1.16M28.27%-1.12M-14.66%-1.54M7.59%-1.52M18.71%-6.08M17.85%-1.53M18.45%-1.56M
Non-operating interest expense -68.98%478K-22.54%1.18M-12.18%5.34M-24.02%1.16M-28.27%1.12M14.49%1.54M-7.76%1.52M-19.91%6.08M-21.80%1.53M-18.71%1.56M
Other net income (expense) -86.78%1.09M108.89%245K376.77%2.42M-82.46%140K-21,300.00%-3.21M593.42%8.25M-30,722.22%-2.76M-171.88%-874K16,060.00%798K-109.20%-15K
Gain on sale of security -87.12%1.06M96.14%-80K811.94%5.43M-96.36%31K-1,303.23%-746K590.39%8.21M-18,954.55%-2.07M-175.45%-762K503.32%851K-61.96%62K
Special income (charges) ---------1,562.91%-2.51M--0---2.51M-----------151K---151K--0
-Less:Impairment of capital assets --------1,562.91%2.51M--0--2.51M----------151K--151K--0
Other non- operating income (expenses) 3.23%32K147.65%325K-1,369.23%-495K11.22%109K161.04%47K675.00%31K-34,000.00%-682K-81.07%39K--98K---77K
Income before tax -41.22%-8.96M24.66%-13.53M19.23%-50.08M-2.39%-10.34M11.22%-15.43M64.81%-6.35M-8.91%-17.97M-25.92%-62M16.84%-10.1M-24.44%-17.38M
Income tax
Net income -41.22%-8.96M24.66%-13.53M19.23%-50.08M-2.39%-10.34M11.22%-15.43M64.81%-6.35M-8.91%-17.97M-25.92%-62M16.84%-10.1M-24.44%-17.38M
Net income continuous Operations -41.22%-8.96M24.66%-13.53M19.23%-50.08M-2.39%-10.34M11.22%-15.43M64.81%-6.35M-8.91%-17.97M-25.92%-62M16.84%-10.1M-24.44%-17.38M
Minority interest income
Net income attributable to the parent company -41.22%-8.96M24.66%-13.53M19.23%-50.08M-2.39%-10.34M11.22%-15.43M64.81%-6.35M-8.91%-17.97M-25.92%-62M16.84%-10.1M-24.44%-17.38M
Preferred stock dividends 330K0330K
Other preferred stock dividends
Net income attributable to common stockholders -41.22%-8.96M24.66%-13.53M19.66%-50.08M-2.39%-10.34M12.88%-15.43M64.81%-6.35M-8.91%-17.97M-26.59%-62.33M16.84%-10.1M-26.81%-17.71M
Basic earnings per share 91.84%-0.6497.98%-2.6698.43%-19.1998.19%-2.547898.83%-3.4598.46%-7.8472.89%-131.7721.15%-1.22K-1,914.29%-141-3,399.41%-294.65
Diluted earnings per share 91.84%-0.6497.98%-2.6698.43%-19.1998.19%-2.547898.83%-3.4598.46%-7.8472.89%-131.7721.15%-1.22K-1,914.29%-141-3,399.41%-294.65
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data

Concept Mpox (monkeypox)
Mpox (monkeypox)
Intraday-0.05%